AmpliMed's Series A Round

AmpliMed raised a round of funding on May 20, 2004.

AmpliMed Corporation, a clinical-stage pharmaceutical company founded by oncologists is focused on a lead compound, Amplimexon, which per AmpliMed has shown early evidence of efficacy and low levels o…

Articles about AmpliMed's Series A Round: